Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.46 |
| ▸ | RAB9A | P51151 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | METAP1 | P53582 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21099056 | 0.98 | KDM4E (0.46) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL21098948 | 0.96 | TSHR (0.46) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL20195361 | 0.94 | KDM4E (0.44) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL18680018 | 0.92 | METAP1 (0.42) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL18680028 | 0.92 | METAP1 (0.42) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL21098923 | 0.92 | HSD17B10 (0.42) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL20195353 | 0.92 | TSHR (0.48) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL20195347 | 0.91 | KDM4E (0.44) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL17829306 | 0.91 | KDM4E (0.50) | SMN1; SMN2RAB9AKDM4ELMNAHPGD | |
| SCHEMBL20010304 | 0.90 | CCR1 (0.45) | SMN1; SMN2RAB9AKDM4ELMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | LG CHEM, LTD. (KR) | 2019-06-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10323006-B2 | Heterocyclic compound and organic light emitting element using same | CRY1, CRY2, NR2E3 | SMN1; SMN2 3226/4885RAB9A 3388/4885KDM4E 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.